Steris Plc Stock Today
| STE Stock | USD 219.06 1.59 0.73% |
Performance0 of 100
| Odds Of DistressLess than 5
|
STERIS Plc is trading at 219.06 as of the 30th of November 2024, a 0.73 percent increase since the beginning of the trading day. The stock's lowest day price was 215.49. STERIS Plc has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Note, on November 11, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of STERIS plc's common stock.
Business Domain Health Care Equipment & Services | IPO Date 1st of June 1992 | Category Healthcare | Classification Health Care |
STERIS plc provides infection prevention and other procedural products and services worldwide. The company was founded in 1985 and is based in Dublin, Ireland. Steris Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 98.71 M outstanding shares of which 755.64 K shares are at this time shorted by investors with about 1.12 days to cover. More on STERIS plc
Moving together with STERIS Stock
Moving against STERIS Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
STERIS Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Walter Rosebrough | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Stewart & Wight plc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Obamacare Repeal, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSTERIS Plc can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand STERIS Plc's financial leverage. It provides some insight into what part of STERIS Plc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STERIS plc (STE) is traded on New York Stock Exchange in USA. It is located in 5960 Heisley Road, Mentor, OH, United States, 44060 and employs 18,000 people. STERIS Plc is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 21.62 B. STERIS plc runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 98.71 M outstanding shares of which 755.64 K shares are at this time shorted by investors with about 1.12 days to cover.
STERIS plc has about 208.36 M in cash with 973.27 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.16.
Check STERIS Plc Probability Of Bankruptcy
Ownership AllocationSTERIS plc shows a total of 98.71 Million outstanding shares. The majority of STERIS plc outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in STERIS Plc to benefit from reduced commissions. Therefore, institutions are subject to a different set of regulations than regular investors in STERIS plc. Please pay attention to any change in the institutional holdings of STERIS plc as this could imply that something significant has changed or is about to change at the company. Please note that on November 11, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of STERIS plc's common stock.
Check STERIS Ownership Details
STERIS Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Sustainable Growth Advisers, Lp | 2024-09-30 | 1.4 M | |
| Norges Bank | 2024-06-30 | 1.2 M | |
| Impax Asset Management Group Plc | 2024-06-30 | 1.2 M | |
| Northern Trust Corp | 2024-09-30 | 1.1 M | |
| Pictet Asset Manangement Sa | 2024-06-30 | 1.1 M | |
| Bessemer Group Inc | 2024-06-30 | 1.1 M | |
| Principal Financial Group Inc | 2024-09-30 | 1.1 M | |
| Mitsubishi Ufj Asset Management Co.,ltd | 2024-09-30 | 1.1 M | |
| Bank Of America Corp | 2024-06-30 | 1 M | |
| Vanguard Group Inc | 2024-09-30 | 12 M | |
| Blackrock Inc | 2024-06-30 | 9.2 M |
STERIS Plc Historical Income Statement
STERIS Stock Against Markets
STERIS Plc Corporate Directors
| Richard Breeden | Independent Director | Profile | |
| Michael Wood | Independent Director | Profile | |
| Paul Martin | Independent Director | Profile | |
| Jacqueline Kosecoff | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.305 | Dividend Share 2.13 | Earnings Share 5.96 | Revenue Per Share 53.903 | Quarterly Revenue Growth 0.073 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.